Status:
AVAILABLE
Karyopharm Expanded Access Program for Selinexor
Lead Sponsor:
Karyopharm Therapeutics Inc
Collaborating Sponsors:
Caligor Coghlan (CalCog)
Conditions:
Multiple Myeloma
Diffuse Large B-Cell Lymphoma (DLBCL)
Brief Summary
KEAP is an expanded access program designed to provide selinexor to eligible participants outside of a clinical trial before the drug has been given marketing approval by the country's regulatory agen...
Eligibility Criteria
Inclusion
- \-
Exclusion
- \-
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT07215832
Last Update
October 14 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.